Acurx Pharmaceuticals, Inc. General form of registration statement for all companies including face-amount certificate companies

General form of registration statement for all companies including face-amount certificate companies

ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Tables)

ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Tables)

9 Months Ended

12 Months Ended

Sep. 30, 2024

Dec. 31, 2023

ACCOUNTS PAYABLE AND ACCRUED EXPENSES

Summary of accounts payable and accrued expenses


		September 30, 2024			December 31, 2023
Accrued research and development		$	2,968,508		$	2,263,934
Accrued compensation expenses			247,210			716,307
Accrued professional fees			83,950			58,388
Other accounts payable and accrued expenses			19,097			3,809
Total		$	3,318,765		$	3,042,438


		December 31, 2023			December 31, 2022
Accrued compensation expenses		$	716,307		$	542,895
Accrued research and development			2,263,934			1,405,536
Accrued professional fees			58,388			83,715
Other accounts payable and accrued expenses			3,809			29,539
Total		$	3,042,438		$	2,061,685